Matinas BioPharma Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

Stockholders' Equity (Details Narrative) - USD ($)									3 Months Ended		12 Months Ended
Stockholders' Equity (Details Narrative) - USD ($)	Mar. 28, 2019	Mar. 19, 2019	Mar. 19, 2019	Jun. 21, 2018	Jun. 21, 2018	Jun. 19, 2018	Sep. 12, 2016	Jul. 29, 2016	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2016	Dec. 31, 2018	Aug. 16, 2016
Net proceeds from offering		$ 27,900,000							$ 30,168,307
Common stock par value									$ 0.0001			$ 0.0001
Warrants [Member]
Number of warrant to purchase of common stock									5,799,429
Issuance of warrants description									The Company may call the warrants, other than the Placement Agent Warrants, at any time the common stock trades above $ 3.00 (for 20 million warrants issued in 2015) for twenty (20) consecutive days
Placement Agency Agreement [Member]
Gross proceeds of shares issued				$ 8,000,000
Net proceeds of shares issued				$ 7,100,000
Percentage of gross proceeds				7.00%
Percentage of non- accountable expenses				1.00%
Placement Agency Agreement [Member] \| 2018 Placement Agent Warrants [Member]
Number of warrant to purchase of common stock				240,000	240,000
Fair value of warrants					$ 89,000
Class of warrant or right, exercise price of warrants or rights				$ 0.75	$ 0.75
Warrant term				5 years	5 years
Series A Preferred Stock [Member]
Preferred stock shares authorized									10,000,000
Preferred stock par value									$ 0.001
Preferred stock shares designated									1,600,000
Preferred stock, shares outstanding									1,467,858
Preferred stock conversion basis									Series A Preferred Stock to be converted, multiplied by the stated value of $5.00 (the "Stated Value"), divided by the Conversion Price in effect at the time of the conversion (the initial conversion price is $0.50, subject to adjustment in the event of stock splits, stock dividends, and a "fundamental transaction").
Conversion price per share									$ 0.50
Number of preferred stock shares converted									14,678,580
Sale of stock price per share							$ 1.00	$ 0.67					$ 0.70
Intrinsic value									$ 4,400,000
Beneficial conversion feature amount											$ 4,400,000
Beneficial conversion feature percentage											100.00%
Dividend rate								8.00%	8.00%
Paid in kind dividend									$ 1,200,000
Dividend accumulated									$ 600	$ 600
Royalty percentage							4.50%		7.50%
Series A Preferred Stock [Member] \| Sales Revenue, Net [Member]
Royalty percentage									4.50%
Series B Preferred Stock [Member]
Preferred stock shares undesignated						8,000
Preferred stock, shares outstanding									4,730
Conversion price per share									$ 0.50
Number of preferred stock shares converted									2,000
Dividend accumulated									$ 300
Number share issued upon conversion									89
Stock conversion percentage									0.501
Beneficial ownership limitation description									The Beneficial Ownership Limitation, or such holder, together with such holder's affiliates, and any persons acting as a group together with such holder or affiliates, would beneficially own in excess of the Beneficial Ownership Limitation. The "Beneficial Ownership Limitation" is 4.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion of Series B Preferred Stock held by the applicable holder. A holder may, prior to issuance of the Series B Preferred Stock or, with 61 days prior notice to us, elect to increase or decrease the Beneficial Ownership Limitation; provided, however, that in no event may the Beneficial Ownership Limitation exceed 9.99%.
Liquidity value and dividends, description									(i) a number of shares of common stock equal to 10% of the shares of common stock underlying the Series B Preferred Stock then held by such holder on the 12 month anniversary of the COD Effective Date, (ii) a number of shares of common stock equal to 15% of the shares of common stock underlying the Series B Preferred Stock then held by such holder on the 24-month anniversary of the COD Effective Date and (iii) a number of shares of common stock equal to 20% of the shares of common stock underlying the Series B Preferred Stock then held by such holder on the 36-month anniversary of the COD Effective Date. In the event a purchaser in this offering no longer holds Series B Preferred Stock as of the 12-month anniversary, the 24-month anniversary or the 36-month anniversary, such purchaser will not be entitled to receive any dividends on such anniversary date.
Liquidation value of preferred share value									$ 1,000
Series B Convertible Preferred Stock [Member]
Preferred stock shares authorized									8,000			8,000
Preferred stock par value									$ 1,000			$ 1,000
Preferred stock, shares outstanding									4,730			4,819
Series B Convertible Preferred Stock [Member] \| Placement Agency Agreement [Member]
Preferred stock par value						$ 0.0001
Number share issued upon conversion						8,000
Preferred stock stated value						$ 1,000
Common Stock [Member] \| Placement Agency Agreement [Member]
Conversion price per share						$ 0.50
Number share issued upon conversion						16,000,000
Common stock par value						$ 0.0001
Number of common shares issued						7,200,000
Maximum [Member] \| Warrants [Member]
Class of warrant or right, exercise price of warrants or rights									$ 0.75
Minimum [Member] \| Warrants [Member]
Class of warrant or right, exercise price of warrants or rights									0.50
Holders [Member] \| Series B Preferred Stock [Member]
Conversion price per share									$ 0.50
Number of preferred stock shares converted									9,460,000
BTIG, LLC [Member]
Offering sale of public shares	2,199,259		27,272,727
Price per share	$ 1.10	$ 1.10	$ 1.10
Gross proceeds from offering			$ 30,500,000
Net proceeds from offering	$ 2,300,000		$ 27,900,000
BTIG, LLC [Member] \| Underwriters [Member] \| Maximum [Member]
Number of options to purchase common stock			4,090,909